Jun Sugimoto
Hiroshima, 7348551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia.
Journal: Scientific reports
Published: May 29, 2025
Indoleamine 2,3-Dioxygenase Regulates Placental Trophoblast Cell Invasion.
Journal: International journal of molecular sciences
Published: May 16, 2025
Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: February 26, 2025
The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy.
The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy.
Journal: International journal of molecular sciences
Published: February 13, 2024
Controlling Trophoblast Cell Fusion in the Human Placenta-Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1.
Journal: Biomolecules
Published: August 14, 2023
Progesterone Suppresses Uterine Contraction by Reducing Odontogenic Porphyromonas gingivalis Induced Chronic Inflammation in Mice.
Journal: Biomolecules
Published: June 20, 2022
Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta.
Journal: Scientific reports
Published: March 09, 2022
Could the Human Endogenous Retrovirus-Derived Syncytialization Inhibitor, Suppressyn, Limit Heterotypic Cell Fusion Events in the Decidua?
Journal: International journal of molecular sciences
Published: August 31, 2021
The Immunology of Syncytialized Trophoblast.
Journal: International journal of molecular sciences
Published: December 31, 2020
Last Updated: 09/26/2026